Abstract We evaluated the effect of oral calcium supplementatIon on blood pressure, calcium metabolism, and msuhn resistance m essential hypertension After receiving a standard diet with 500 mg of calcmm per day durmg a 4-week period, 20 nondiabetic, essential hypertensive patients were randomized in a double-blind fashion to receive oral calcium supplementation (1500 mg of calcium per day) or placebo for 8 weeks At the end of the 4-week period of low-calcium diet and after the 8-week period of intervention, we measured blood pressure (by both office and 24-hour ambulatory blood pressure momtonng), calaum-regulating hormones [urinary hydroxyprohne and serum osteocalcm, parathormone, and l,25(OH)2-vltamm DJ, mtraplatelet free calcium concentration, fasting plasma glucose and insulin levels, and the msuhn-sensitivity index (euglycenuc-hypermsuhnetmc clamp). Compared with patients maintained at low calcium intake, essential hypertensive patients under oral calcium supplementation significantly reduced serum osteocalcm (from 222+1 9 to 17 9220 pg/L, P= 001.5), parathormone (from 4 2020 38 to 3 30?0 36 pmol/L; P= 0003), and 1,25(OH)2-vltarnm D1 (from 98 0211 0 to 61 625 7 pmol/L, P=.OO62) LIkewise, we found a significant reduction m mtraplatelet free calcium concentration (from 35 92 1.2 to 26 520 8 nmol/L; P= 0005) and fastmg plasma msulm levels (from 71 85.5 9 to 64 6?6 2 pmol/L, P= 05) and a significant increase m the msulm-sensitivity index (from 2 8920.77 to 4 0050 95 mg kg-' nun-', P= 0007) None of these parameters were significantly modified m patients maintained at low calcium rntake Office and 24-hour mean values of systolic and dlastohc blood pressure did not change after 8 weeks of oral calcium supplementation or placebo (Hypertension. 1997;29[part 21: 531-536 Essential hypertension IS associated with increased calcium concentration in several cell types 5-7 In animal models with experimental hypertensloqs-10 calcium supplementation leads to a decrease m intracellular calcmm, which IS postulated as one of the mechanisms of the BP fall Furthermore, m black hypertensive patients, it has been reported that high calcium intake prevents the increase m intracellular calcmm promoted by a high salt diet 11
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Essential hypertension IS associated with increased calcium concentration in several cell types 5-7 In animal models with experimental hypertensloqs-10 calcium supplementation leads to a decrease m intracellular calcmm, which IS postulated as one of the mechanisms of the BP fall Furthermore, m black hypertensive patients, it has been reported that high calcium intake prevents the increase m intracellular calcmm promoted by a high salt diet 11
Several studies have demonstrated the existence of some degree of msulm resistance and/or hypermsulmemla m patients with essential hypertension and an mverse relation between BP and msulm-mediated glucose disposal.l2,'3 An important relationship IS likely to exist between alterations m intracellular calcium metabolism, insulin resistance, and hypertension 14 There are several From the Hypertension Unit, Departments of Internal Medicine and Nephrology (E P), Hospital Clime, Umverslty of Barcelona, Spam Correspondence to Alejandro de la Sierra, MD, Hypertension Unit, Department of Internal Medicine, Hospital Clime, Vlllarroel 170, 08036-Barcelona, Spam E-mail lserte@mechcma ub es 0 1997 American Heart Assoaatlon, Inc data suggesting that "optimal" levels of intracellular free calcium concentration are necessary for maximal cellular action of insulin 15.16 The increased intracellular calcium content reported m essential hypertension might affect insulin action in muscle cells, since it is partially responsible for msulm resistance I6 Therefore, it could be speculated that the expected reduction m intracellular calcium induced by oral calcium supplementation could improve cellular msulm metabolism and partially correct msulm resistance. Based on these considerations, the am of the present study was to analyze the effect of oral dietary calcium supplementation on BP, calcium metabolism, and mtraplatelet free calcmm concentration, as well as on insulin sensitivity, m essential hypertensive patients.
Methods

Patient Selection
Twenty previously untreated, mild-to-moderate essential hypertensive patients (12 men and 8 women) aged 25 to 56 years old (meantSEM, 44 628 3 years) were consecutively recrmted from the Hypertension Unit of the Hospital Chnlc, Barcelona, Spain The diagnosis of essential hypertension was considered on the basis that no known cause of high BP could be detected after complete chnical, biochemical, and radrological exammation None of the patients had renal impairment, papdloedema, or evldence of cardiac failure or coronary or cerebrovascular diseases Patients with a definite diagnosis of diabetes mellltus or those with an abnormal oral glucose tolerance test were excluded form the study All patients had at least three office BP measurements 
Study Protocol
The study was approved by the Ethics Committee of the hospital, and wntten informed consent was obtained from all partrclpants A low-calcmm diet containing 3500 mg of calcmm per day was given to all patients for 4 weeks The dtetary advice was prepared by an expert dtetman and was basrcally achieved by ehmmatmg dairy products Patients were visited weekly at the Hypertension Unit, office SBP and DBP were measured, and complmnce with the diet was assessed by means of direct mterview. Patients were advised to keep then intake of calones, salt, and alcohol, as well as then exercise level, constant for the whole study period
At the end of this run-m period, patients were randomized m a double-blind fashion to receive placebo tablets (n= 10) or calcium tablets (n=lO) (Calcmm Sandoz, Sandoz Pharma, 1500 mgld) for an &week period, m addition to the same basal lowcalcmm diet
The last day of both run-m and mterventron pertods, BP was measured by 24-hour ABPM Serum and 24-hour urinary calcmm and phosphate, calcitropic hormones [urinary hydroxyprolme, serum osteocalcm, parathormone, and 1,25(0H),-vrtamm Ds], plasma glucose, and plasma msulm levels were measured Intraplatelet free calcmm concentration was measured by the FURAtechnique, and the msulm sensmvrty index was estimated by the euglycemrc-hypermsulmemrc clamp technique
Blood Pressure Measurements
OfJce BP Measurement Every week throughout the study, a mercury-m-glass sphygmomanometer was used to measure BP three times m succession at 3-minute intervals, after a lo-minute rest m the srttmg position, with the arm supported on a cushion and the cuff at heart level SBP was recorded at the appearance of the Korotkoff sounds (phase I) and DBP at their disappearance (phase V) BP values were estimated as the mean of the three readings All measurements were performed by the same nurse using the same manometer Noninvasive 24-Hour ABPM Twenty-four-hour ABPM was performed using an automated, nonmvasrve, osctllometnc device (SpaceLabs 90207, SpaceLabs Inc) The appropriate cuff was placed on the nondommant arm, and BP was registered automattcally at 15-minute intervals for a 24-hour period Mean values and standard devtatron of SBP and DBP were obtained from each record m the 24-hour penod
Measurement of Platelet Calcium Concentration
Twenty mtllrhters of venous blood was drawn mto 20% (vol/ vol) citrate-dextrose solutron (contammg 2 5 g sodium citrate, 1 5 g citric acid, 2.0 g dextrose m 100 mL drstrlled water) and was centrifuged at 200g for 10 minutes at 20°C to obtain the PRP The PRP was centrifuged at 500g for 20 minutes at 20°C m the presence of (50% vol/vol) adenosme (0 28 g/dL) and theophyllme (1 g/dL) dissolved m CCD, and the pellet was resuspended m HBS contammg NaCl 145 mmol/L, KC1 5 mmol/L, MgC& I mmol/L, glucose 6 mmol/L, HEPES 10 mmol/L, and bovine serum albumin 0.2 mg/mL The pH was adjusted to 7 4 at 37°C The platelet suspension was incubated for 35 minutes at 37°C m a shaking water bath with 2 mmol/L Futa 2-AM The labeled platelets were washed by centrtfugatron and resuspensron m HBS, adjusting platelet count to 0 5X lO*/mL with a Techmkon H-l system Coulter counter (Techmkon Instruments Corp) After an eqmhbratron period of 15 minutes at 37°C m the presence of 1 mmol/L of CaCl*, 2 mL of the platelet suspensron was placed m a quartz cuvette for fluorescence measurements, which were camed out m a Hitachi F-2000 spectrofluorometer (Hitachi Ltd) The fluorescence signal was obtained once every second with alternate excnatton wavelengths (nm). and platelet cytosohc calcium concentratton ([Cal,) was estimated by the ratio of the excitation wavelengths 340/380 The emrsston wavelength was 510 for FuraFor calculatron of [Cal,, the relationshtp between fluorescence ratio at 340/380 (R) and [Ca"], was obtained using the equattont7
where R,,, 1s the fluorescence ratio at saturating calcmm (range, 5 8 to 9 1, mean, 7 6), R,,,, is the ratio at zeta calcmm (range, 0 7 to 0 9, mean, 0 79), and F,,, and F,,, are the fluorescence readings at 380 nm at zero and saturating calcmm, respectively (ratio range, 4 3 to 6 5, mean, 4 5) Kd 1s the effective drssoctatton constant of Fura-m appropriate condmons and was taken to be 224 nmol/L '7 Cahbratron was performed by the followmg procedure After each experiment, cells were lysed with drgttomn (50 pmol/L) m the presence of 1 mmol/L of CaCl, to obtain R,,, and F,,, Thereafter, to obtam R,,, and F,,,, EGTA (6 mmol/L) was added and the pH of the cuvette was adjusted to 8 3 with 20 mmol/L Tns base
Measurement of Insulin Resistance
The studies were carried out on the last day of both the run-m and mterventton periods, beginning at 8 30 AM after an overnight fast (10 to 14 hours), with the subjects lymg supine in a quiet room with a constant temperature of 21°C Polyethylene cannulas were inserted mto an antecubttal vem (for mfusron of test substances) and retrogradely mto a wrist vem surrounded by a heated (~70°C) box (for blood sampling) Use of the box ensures artenahzatton of venous blood wrthm 20 to 40 minutes r* Insulm sensrttvtty was assessed with the use of the euglycemtchypermsulmemtc clamp technique 19 Briefly, a pnmed constant mfusron of msulm (Actraprd HM, Novo Industries) was admmrstered for 120 minutes at a rate of 40 mU per square meter of body-surface area per minute to achieve hypennsulmemra (an insulin level of ~100 @J/mL [=700 pmol/L]) Plasma glucose concentratron was held constant at baseline by a variable-rate infusion of exogenous glucose, which was adjusted on the basis of frequent blood glucose measurements The amount of glucose required to mamtam rsoglycemra equals whole-body disposal of glucose, provided that endogenous glucose productron 1s essentially absent The quantity of glucose infused during the final 60 minutes, corrected for body-surface area, provided an index of the msulm sensmvtty of the whole body (expressed m terms of the number of mtlhgrams of glucose infused per kilogram of body weight per minute)
Blood samples were obtamed during the baseline period and then every 20 minutes until the end of the study Plasma glucose was assayed by the glucose oxrdase method (Beckman Glucose Analyzer, Beckman Instruments) Serum msulm concentratrons were determined by radtotmmunoassay
Statistical Analysis
Values are expressed by then mean?SEM Differences between groups at baseline and at the end of the treatment period were analyzed by means of nonparametric Mann-Whitney and Wrlcoxon tests The relationship between mtracellular calcmm and insulin sensmvrty at baseline was examined by means of nonparametrtc Spearman's rank correlatton coefficient The sta- 
Results
At the end of the &week period of low calcium diet, no significant differences were observed between patients randomized to placebo (n=lO) or calcmm supplementation (n= IO) m any of the parameters studied (Tables 1 and  2 ). In the entire group of essential hypertensive patients, we observed a sigmficant inverse relationship between platelet free calcmm concentration and insulin sensitivity index (Spearman's rank correlation coefficient, -5253; P<.O5). Conversely, baseline values of calcitroptc hormones did not correlate with msulm sensitivity BP Changes Induced by High Calcium Intake Table 3 shows mean values (?SEM) of office SBP and DBP at a-week intervals throughout the study No sigmficant changes were observed m patients receiving oral calcium supplementation with respect to the placebo group Table 1 shows mean values (+SEM) of 24-hour SBP and DBP at the end of the run-m and double-blind periods m both groups of patients studied Compared with the placebo group, no significant changes m 24-hour SBP or DBP were observed in patients receivmg calcium supplementation.
Changes in Calcium Metabolism Induced by High Calcium Intake Table 1 also shows mean values of the different calcium metabolism parameters studied m both placebo and calcium groups at baseline and at the end of the mtervention period Both serum and urinary calcmm and phosphate and urinary hydroxyprolme were not modified m the two groups Conversely, compared with the placebo group, oral calcium supplementation promoted a decrease in serum osteocalcm ( 
Changes in Glucose Metabolism Induced by High Calcium Intake
Ag 2 shows individual changes m the msulm sensitivity index m both placebo and calcium groups Compared with patients mamtamed on a low calcmm diet, oral calcium supplementatton significantly increased the msulm sensitivity index (from 2.89~0.77 to 4.0020.95 mg* kg-' mm-', P= 0007) (Table 2) As is also shown m Table 2, this increase in the insulin sensitivity index was accompanied by a decrease in fasting plasma msulm (from 71 825.9 to 64 6?6 2 pmol/L; P=.O5) Finally, fasting plasma glucose was not significantly affected by the level of calcium intake.
Discussion
The present study shows that a short period (8 weeks) of high calcium intake (-2 g/d) reduces intraplatelet free calcium concentratton and positively affects glucose metabolism, mcreasmg insulin sensitivity and decreasing T the present study we did not observe any significant effect of calcmm on BP, assessed by means of either weekly office measurements or 24-hour ABPM It is important to note that this lack of effect of calcium supplementatton on BP may be influenced by the well-known heterogeneity of the hypertensive population In this sense, salt-sensitive patients with low-rerun hypertension are more prone to have a calcmm-deficient state and, consequently, to respond to oral calcmm supplementation with a fall m BP, whereas salt resistance with normal or high-renm hypertension does not respond to changes m calcmm mtake,2rJ* Several mechanisms have been proposed to explain the antihypertensive effect of calcium These include a natrmretic effect,23 a decrease m calcmm-regulating hormones*+*5 (which may have a vasoactive effect), and a decrease m intracellular free calcmm concentratton,8-11 which Induces vasorelaxatton. Calcmm-regulating hormones are sensitive to changes in dietary calcium consumption and serum ionized calcium. It has been demonstrated that the reduction of dtetary calcmm increases plasma levels of parathormone,*6,*7 calcltrlol [1,25(0H)2-vltamm D-,1,*6** osteocalcm,z8 and the urinary excretion of hydroxyprohne 27.28 On the other hand, the increase m dietary calcmm reduces parathormone*4*5 and calcttrrol.2~ There 1s emerging evidence that these hormones may play a role m BP regulatron. It has been reported that parathormone may increase calcmm entry m heart cells,*" and increased levels of this hormone have been found m essential hypertensive patients.yO Moreover, calcrtrtol has been shown to enhance contractile properties m resistance arteries of both normotenstve and hypertensive animals,31 and increased plasma levels have also been found m essential hypertensive patients.30 In our study, we have observed a significant decrease m both parathormone and calcrtrtol m patients receiving oral calcmm supplementation However, on the basis of the present evidence, a relationship between the decrease m the plasma levels of these hormones and mtraplatelet free calcium concentration is merely speculative Increased mtracellular free calcmm concentration 1s a common feature m essential hypertensive patients that has been proposed as the responsible mechanism of mcreased vascular peripheral resistance and BP 5-7 Oshtma et a18 reported that calcmm supplementation m stroke-prone spontaneously hypertensive rats decreased mtracellular free calcium concentration m both ctrculatmg platelets and lymphocytes Furthermore, m black hypertensive patients, tt has been reported that high calcmm intake prevents the increase m intracellular calcmm promoted by high salt diet 11 Our results are in agreement with those previously reported Essentral hypertensive patients treated with oral calcmm supplementation decreased mtraplatelet free calcium concentratron m ~25% of their basal values, whereas patients receiving placebo did not exhibit any significant change As shown m Ftg 1, mtraplatelet calcium decreased in all but one patient treated with calcmm supplements.
The existence of a relationship between intracellular calcmm concentration and msuhn metabolism has been proposed 14 In experimental studies, msulm-mediated glucose transport is affected by mcreasmg the mtracellular level of calcium. 15~6 Furthermore, hypertensive non-msulm-dependent diabetics, who are msulm reslstant, exhibit a reduction m Ca*+-ATPase and an increase m intracellular calcium compared with nondiabetic hypertenslves 32 This relationship has been confirmed m the present work We have observed a correlation between mtraplatelet free calcium concentration and msulm sensitivity index m the entire group of hypertensive patients studied after a 4-week period of low calcium diet Furthermore, we hypothesized that reducing mtraplatelet calcium would affect msulm metabolism Our results confirmed this hypothesis In fact, the reduction of mtraplatelet calcium achieved with oral calcium supplementation was associated with an mcrease m the msulm sensttivrty index and a decrease m plasma fastmg msulm levels None of these parameters were affected m patients maintained at low calcmm mtake, who dtd not reduce mtraplatelet calcium These results are m agreement with those obtained by Resnick and Laragh 33 Those authors observed that patients who presented a fall m BP after 1 month of oral calcium supplementation exhibited an amelioration of carbohydrate metabolism with both a decrease m the area under the curve of glucose and an increase m the msulm response after an oral glucose tolerance test.
In concluston, oral calcium supplementation reduces intraplatelet calcmm concentratton, even without a srgmficant effect on BP, assessed by means of 24-hour ABPM This reduction m mtraplatelet calcium 1s associated with a reduction m the msulm resistance and m ctrculatmg fastmg plasma msulm levels 
